Usefulness of endothelinA receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia-Reference-Cited by-同舟云学术

Usefulness of endothelinA receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia

Published:2003-02 Issue:4 Volume:91 Page:476-479
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kyriakides Zenon S.,Psychari Stavroula N.,Kolettis Theofilos M.,Georgiadis Michael,Antoniadis Aias,Kremastinos Dimitrios T.h.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty;Tahara;Metabolism,1992

2. Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischemia;Kyriakides;Eur Heart J,1995

3. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling;Kirchengast;Proc Soc Exp Biol Med,1999

4. Selective ETA receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model;McKenna;Circulation,1998

5. Effects of L-749,329, an ETA/ETBendothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis;Huckle;Circulation,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of intimal hyperplasia of the vein graft with degradable poly lactic-co-glycolic acid vascular external sheaths carrying slow-release bosentan;European Journal of Cardio-Thoracic Surgery;2015-02-26

2. Ambrisentan, a Non-peptide Endothelin Receptor Antagonist;Cardiovascular Drug Reviews;2006-03

3. The drug-based pipeline against restenosis;Expert Opinion on Emerging Drugs;2005-02

4. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies;Current Opinion in Lipidology;2003-12

5. Plasma endothelin-1 levels after coronary stenting in humans;The American Journal of Cardiology;2003-11